Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Apr 16, 2021
Targets & Mechanisms

New targets featured at AACR signal growing opportunity in established mechanisms

Protein degraders, ion channel regulators and novel checkpoints are among new targets presented at AACR21
BioCentury | Apr 11, 2017
Distillery Techniques

Disease models

BioCentury | Feb 8, 2016
Company News

UCSD, PsychoGenics deal

BioCentury | Mar 30, 2015
Company News

UCSD, PsychoGenics deal

BioCentury | Jun 5, 2014
Distillery Techniques

Technology: Drug platforms

BioCentury | Aug 25, 2011
Tools & Techniques

Taking out teratoma potential

BioCentury | Aug 18, 2011
Distillery Techniques

Technology: Drug platforms

BioCentury | Jan 22, 2009
Distillery Therapeutics

Indication: Hematology

BioCentury | Feb 21, 2008
Distillery Therapeutics

This Week in Therapeutics

Items per page:
1 - 10 of 10